Home›Signals›Short Interest
📉

Short Interest

Heavily shorted biotech stocks and squeeze potential

50 Active Signals
WOKWORK Medical Technology Group LTD Class ABiotech / Pharma
Short interest: 37.92% of float, squeeze risk: MODERATE SI: 37.92%
F
33/100
WGRXWellgistics Health, Inc.Biotech / Pharma
Short interest: 411.59% of float, squeeze risk: MODERATE SI: 411.59%
F
33/100
SPRYSpruce BiosciencesEndocrinology
Short interest: 61.04% of float, squeeze risk: HIGH SI: 61.04%
D
39/100
QUCYMainz Biomed N.V.Biotech / Pharma
Short interest: 82.88% of float, squeeze risk: MODERATE SI: 82.88%
F
14/100
MNPRMonopar Therapeutics Inc.Biotech / Pharma
Short interest: 38.0% of float, squeeze risk: HIGH SI: 38%
D
40/100
MNDRMobile-health Network Solutions Class ABiotech / Pharma
Short interest: 33.28% of float, squeeze risk: MODERATE SI: 33.28%
F
19/100
MISTMilestone MedicalOphthalmology IOP
Short interest: 53.21% of float, squeeze risk: MODERATE SI: 53.21%
D
47/100
LBGJLi Bang International Corporation Inc. Class ARNA Therapy
Short interest: 109.08% of float, squeeze risk: MODERATE SI: 109.08%
F
15/100
KALVKalVista Pharmaceuticals, Inc.Biotech / Pharma
Short interest: 31.57% of float, squeeze risk: MODERATE SI: 31.57%
D
40/100
INBXInhibrx IncOncology / Rare
Short interest: 37.33% of float, squeeze risk: MODERATE SI: 37.33%
D
40/100
FDMT4D Molecular Therapeutics, Inc.Biotech / Pharma
Short interest: 31.11% of float, squeeze risk: HIGH SI: 31.11%
D
40/100
CMNDClearmind Medicine Inc. Common SharesBiotech / Pharma
Short interest: 98.43% of float, squeeze risk: MODERATE SI: 98.43%
F
18/100
ACRVAcrivon Therapeutics, Inc.Biotech / Pharma
Short interest: 44.58% of float, squeeze risk: MODERATE SI: 44.58%
D
43/100
ABEOAbeona Therapeutics Inc.Biotech / Pharma
Short interest: 32.44% of float, squeeze risk: HIGH SI: 32.44%
D
43/100
TNGXTango Therapeutics, Inc.Biotech / Pharma
Short interest: 45.7% of float, squeeze risk: HIGH SI: 45.7%
D
40/100
SNSESensei Biotherapeutics, Inc.Biotech / Pharma
Short interest: 100.45% of float, squeeze risk: HIGH SI: 100.45%
D
40/100
SLXNSilexion Therapeutics CorpBiotech / Pharma
Short interest: 38.34% of float, squeeze risk: MODERATE SI: 38.34%
F
33/100
SLSSELLAS Life Sciences Group, Inc.Biotech / Pharma
Short interest: 30.81% of float, squeeze risk: HIGH SI: 30.81%
D
43/100
RXRXRecursion PharmaceuticalsAI Drug Discovery
Short interest: 35.95% of float, squeeze risk: HIGH SI: 35.95%
D
38/100
RLMDRelmada Therapeutics, Inc.Biotech / Pharma
Short interest: 71.1% of float, squeeze risk: HIGH SI: 71.1%
D
41/100
PPCBPropanc Biopharma, Inc.Biotech / Pharma
Short interest: 37.75% of float, squeeze risk: MODERATE SI: 37.75%
F
21/100
NVAXNovavax IncVaccines
Short interest: 32.01% of float, squeeze risk: HIGH SI: 32.01%
D
40/100
NTLAIntellia TherapeuticsGene Editing
Short interest: 38.65% of float, squeeze risk: HIGH SI: 38.65%
D
44/100
MDGLMadrigal PharmaceuticalsLiver Disease
Short interest: 30.2% of float, squeeze risk: HIGH SI: 30.2%
D
45/100
LNAILunai Bioworks Inc.Biotech / Pharma
Short interest: 74.35% of float, squeeze risk: MODERATE SI: 74.35%
F
14/100
LENZLENZ Therapeutics, Inc.Biotech / Pharma
Short interest: 60.04% of float, squeeze risk: HIGH SI: 60.04%
D
44/100
KPTIKaryopharm TherapeuticsOncology
Short interest: 35.91% of float, squeeze risk: HIGH SI: 35.91%
D
40/100
IBRXImmunityBio, Inc.Biotech / Pharma
Short interest: 33.69% of float, squeeze risk: HIGH SI: 33.69%
D
41/100
HIMSHims & Hers Health, Inc.Biotech / Pharma
Short interest: 30.05% of float, squeeze risk: MODERATE SI: 30.05%
D
37/100
HCWBHCW Biologics Inc.Biotech / Pharma
Short interest: 62.5% of float, squeeze risk: MODERATE SI: 62.5%
D
40/100
HAOHaoxi Health Technology Limited Class ABiotech / Pharma
Short interest: 674.15% of float, squeeze risk: MODERATE SI: 674.15%
A
83/100
CELCCelcuity IncOncology
Short interest: 35.65% of float, squeeze risk: HIGH SI: 35.65%
C
58/100
BEAMBeam TherapeuticsBase Editing
Short interest: 30.14% of float, squeeze risk: HIGH SI: 30.14%
B
71/100
AUTLAutolus TherapeuticsCell Therapy
Short interest: 41.34% of float, squeeze risk: HIGH SI: 41.34%
F
15/100
ADILAdial Pharmaceuticals, IncBiotech / Pharma
Short interest: 33.78% of float, squeeze risk: MODERATE SI: 33.78%
A
92/100
ACXPAcurx Pharmaceuticals, Inc.Biotech / Pharma
Short interest: 38.36% of float, squeeze risk: MODERATE SI: 38.36%
D
43/100
WOKWORK Medical Technology Group LTD Class ABiotech / Pharma
Short interest: 37.92% of float, squeeze risk: MODERATE SI: 37.92%
F
33/100
WGRXWellgistics Health, Inc.Biotech / Pharma
Short interest: 411.59% of float, squeeze risk: MODERATE SI: 411.59%
F
33/100
SPRYSpruce BiosciencesEndocrinology
Short interest: 61.04% of float, squeeze risk: HIGH SI: 61.04%
D
39/100
QUCYMainz Biomed N.V.Biotech / Pharma
Short interest: 82.88% of float, squeeze risk: MODERATE SI: 82.88%
F
14/100
MNPRMonopar Therapeutics Inc.Biotech / Pharma
Short interest: 38.0% of float, squeeze risk: HIGH SI: 38%
D
40/100
MNDRMobile-health Network Solutions Class ABiotech / Pharma
Short interest: 33.28% of float, squeeze risk: MODERATE SI: 33.28%
F
19/100
MISTMilestone MedicalOphthalmology IOP
Short interest: 53.21% of float, squeeze risk: MODERATE SI: 53.21%
D
47/100
LBGJLi Bang International Corporation Inc. Class ARNA Therapy
Short interest: 109.08% of float, squeeze risk: MODERATE SI: 109.08%
F
15/100
KALVKalVista Pharmaceuticals, Inc.Biotech / Pharma
Short interest: 31.57% of float, squeeze risk: MODERATE SI: 31.57%
D
40/100
INBXInhibrx IncOncology / Rare
Short interest: 37.33% of float, squeeze risk: MODERATE SI: 37.33%
D
40/100
FDMT4D Molecular Therapeutics, Inc.Biotech / Pharma
Short interest: 31.11% of float, squeeze risk: HIGH SI: 31.11%
D
40/100
CMNDClearmind Medicine Inc. Common SharesBiotech / Pharma
Short interest: 98.43% of float, squeeze risk: MODERATE SI: 98.43%
F
18/100
ACRVAcrivon Therapeutics, Inc.Biotech / Pharma
Short interest: 44.58% of float, squeeze risk: MODERATE SI: 44.58%
D
43/100
ABEOAbeona Therapeutics Inc.Biotech / Pharma
Short interest: 32.44% of float, squeeze risk: HIGH SI: 32.44%
D
43/100
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.